Florida Nears 1 Million Medical Marijuana Patients as Growth Slows

Florida’s medical marijuana program is approaching a major milestone. The bigger question is whether its market is delivering the access, affordability, and competition patients deserve.

Florida had 942,370 qualified medical marijuana patients with active identification cards as of October 9, 2026, according to the Florida Office of Medical Marijuana Use (OMMU). That puts the program 57,630 patients short of one million. The same report lists 782 dispensing locations statewide. knowthefactsmmj.com

Those numbers show the scale of Florida’s medical cannabis program. They also raise an important question: how should the state measure success beyond the number of cards and storefronts?

For patients, the answer includes affordable access, reliable products, and meaningful choices.

Florida Medical Marijuana Patient Growth Slows

In an October 6 report for the Tallahassee Democrat, journalist James Call examined slower patient growth and concerns about competition.

His September year-over-year comparison reported:

Measure	September 2025	September 2026	Change
Registered patients	924,797	941,650	+1.8%
Dispensary locations	734	771	+5.0%

These are the comparison figures used in Call’s reporting, rather than the newer October totals.

The distinction matters: storefronts expanded faster than the patient population in that comparison. But patient enrollment and store counts alone cannot establish whether industry revenue rose or fell.

More locations may make shopping more convenient. Whether they improve affordability, product selection, or service requires additional evidence.

Suncoast NORML Highlights Barriers to Competition

Call’s reporting includes Suncoast NORML Executive Director Chris Cano and Policy Director Gary Stein, who question whether Florida’s licensing structure allows meaningful competition.

It also references cannabis attorney Sally Kent Peebles of Vicente LLP and her appearance on The Rotation. Peebles identified substantial operating and licensing costs as obstacles for smaller businesses.

The policy question their concerns raise is straightforward: can Florida protect patients while making room for more independent businesses?

A system can have hundreds of stores and still make it difficult for a new operator to enter. Counting storefronts tells us where patients can shop. Examining business ownership and entry requirements tells us more about who gets to compete.

What Vertical Integration Means in Florida

Florida’s OMMU describes Medical Marijuana Treatment Centers, or MMTCs, as vertically integrated businesses. They handle cultivation, processing, and dispensing within the licensed business structure. OMMU requires authorization at each of those stages before an MMTC can dispense medical cannabis.

Opening a medical cannabis dispensary therefore involves a broader regulatory framework than opening an ordinary retail shop.

For reform advocates, this creates a practical debate: should businesses have to participate across the supply chain, or should Florida create more opportunities for specialized operators?

Allowing additional business models would be a policy change. Its effects would need to be evaluated against clear standards for testing, accountability, and patient protection.

The goal should be a system where safety requirements serve patients and businesses have a fair opportunity to compete.

Does Slower Patient Growth Mean Cannabis Sales Are Falling?

Not necessarily. Patient enrollment, dispensing volume, and sales revenue measure different things.

Slower enrollment growth does not, by itself, prove that fewer people need medical cannabis. Patient totals do not explain why someone joins the program, renews a card, or leaves.

Likewise, dispensing quantities are different from sales revenue. Milligrams of THC and ounces of smokable marijuana measure quantities dispensed. Dollar sales also depend on prices, discounts, and the products patients purchase.

A useful assessment of Florida’s market should examine several questions together:

• Can patients afford to maintain access?

• Are suitable products consistently available?

• Can patients reach a dispensing location or obtain delivery?

• Are new businesses able to enter and compete?

• Do regulatory requirements improve safety without creating unnecessary barriers?

These are questions for further investigation, rather than conclusions that can be drawn from the patient count alone.

Why This Matters for Tampa Bay Patients

For patients in Tampa, St. Petersburg, Clearwater, and surrounding communities, a statewide milestone becomes meaningful when it translates into practical improvements.

A nearby dispensary matters. So do reliable inventory, clear product information, knowledgeable staff, and prices patients can manage.

Florida should judge its medical cannabis program by those experiences alongside enrollment totals. Reaching one million active cardholders would demonstrate the program’s reach; improving access would demonstrate how well it serves them.

Policy discussions should also make room for patient experiences. Enrollment statistics cannot tell us whether someone struggles to afford ongoing access or has difficulty finding a product that meets their needs.

A Growing Program Needs a Patient-Focused Conversation

Florida’s approach to medical cannabis affects patients and businesses alike. As the program approaches one million active cardholders, policymakers should examine how its rules influence access, competition, and affordability.

A milestone makes a good headline. A program that works better for patients makes a meaningful difference.

Follow Suncoast NORML and The Rotation for conversations about medical cannabis access, industry participation, and Florida cannabis policy reform.

Frequently Asked Questions

How many medical marijuana patients does Florida have in 2026?

Florida’s October 9, 2026, OMMU update lists 942,370 qualified patients with active identification cards. Patient totals should always include a reporting date because OMMU updates them weekly.

Has Florida reached one million medical marijuana patients?

No. The October 9 report puts Florida 57,630 active cardholders below one million.

Does slower patient growth mean medical marijuana sales are declining?

Not necessarily. Enrollment, dispensing quantities, and sales revenue measure different things. Patient growth alone does not establish a revenue trend.

What is a Florida Medical Marijuana Treatment Center?

An MMTC is a state-licensed, vertically integrated medical cannabis business that cultivates, processes, and dispenses cannabis under Florida’s regulatory framework.